Weston Nichols bought $290K of TScan Therapeutics (TCRX)

Executed Dec 13 2024, disclosed Dec 16 2024, 3 days later.

Value, as filed

$290K

100,000 sh × $2.90

Executed

Dec 13 2024

the trade date, as filed

Disclosed

Dec 16 2024

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

-14.6%

-12.5% from execution

Over the 21 trading sessions from the disclosed entry session (Dec 16 2024), the stock returned -14.6% (delay-adjusted); from the execution session (Dec 13 2024), -12.5%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

WN Weston Nichols 10% owner profile →

Weston Nichols (10% owner) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in TCRX. Across 1 priced purchase filing, the average 21-session return was -12.5% from execution and -14.6% from disclosure (delay-adjusted; derived). The largest single filing was $290K of TCRX (100,000 sh × $2.90, as filed), executed Dec 13 2024.

The name

TCRX TCRX TCRX · 2 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→